US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

105.48

+3.483.41%

Volume:3K

Turnover:351.38K

Market Cap:131.85M

PE:- -

High:105.48

Open:103.98

Low:103.98

Close:102.00

52wk High:110.05

52wk Low:68.05

Shares:1.25M

Float Shares:1.25M

Volume Ratio:1.65

T/O Rate:0.27%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Cabaletta Bio Boosts Cash Through Warrant Exercises

Scholar Rock price target raised to $84 from $76 at BMO Capital

Bank of England predicted to raise interest rates this year

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Scholar Rock announces FDA approval of isembyld

Pharming wins FDA nod to extend Joenja use to younger APDS children

Nextbiomedical Targets Global Investors at 2026 KIS BioTech Day

GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings

Bank of America Reveals 5.22% Indirect Stake in Qiagen

Revvity to acquire Human Cell Design

Actinogen Medical Expands ASX-Quoted Share Base

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

CSL Seeks ASX Quotation for New Shares from Employee Incentive Plan

Sandoz invests USD 300 million in new Slovenian biosimilar facility to boost capacity

Ceryvyn Therapeutics Plans Issue of 3 Million Long-Dated Options

Qurient Plans Investor Roadshow at 2026 KIS BioTech Day in Singapore and Hong Kong

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BBP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":105.48,"timestamp":1789656851949,"preClose":101.9998,"halted":0,"volume":3341,"delay":0,"changeRate":0.03411967474446039,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Trading","change":3.4802,"latestTime":"09-17 10:54:51 EDT","open":103.975,"high":105.48,"low":103.975,"amount":351378.6497,"amplitude":0.014755,"askPrice":105.5,"askSize":700,"bidPrice":104.38,"bidSize":600,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":101.9998,"sharesOutstanding":600004,"nav":101.285,"aum":121542550.39,"bidAskSpread":0.002402,"preHourTrading":{"tag":"盘前","latestPrice":101.9998,"preClose":101.9998,"latestTime":"07:00 EDT","volume":1,"amount":101.9998,"timestamp":1789642858616,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":101.73,"preClose":101.9998,"latestTime":"19:30 EDT","volume":32,"amount":3268.2282,"timestamp":1789601403689,"change":-0.2698,"changeRate":-0.002645,"amplitude":0},"volumeRatio":1.653467,"impliedVol":0.2233,"impliedVolPercentile":0.4263},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.653467,"shares":1250004,"dividePrice":0,"high":105.48,"amplitude":0.014755,"preClose":101.9998,"low":103.975,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":105.48,"committee":-0.076923,"eps":0,"divideRate":0,"volume":3341,"delay":0,"ttmEps":0,"open":103.975,"prevYearClose":79.9149,"prevWeekClose":103.4597,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":103.4736,"twentyDayClose":109.9037,"sixtyDayClose":92.7358},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","XLVX","SYNB","IBB","IEIH","BMED","GNMX","RSPH","NVIB","BFRI","MRNX","IDNA","TECB","MRNY","LABU","TBXU","BBP","FRTY","GDOC","BK4585","IYH","MEDI","BK4007","BK4588","PINK","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","MRNX","IBB","GDOC","LFSC","IYH","TBXU","LABU","IDNA","GNMX","BBP","FRTY","BMED","IEIH","RSPH","PSCH","PINK","XLVX","BK4588","TECB","BK4585","MRNY","SYNB","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666613","title":"Cabaletta Bio Boosts Cash Through Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666613","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666613?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:31","pubTimestamp":1789389071,"startTime":"0","endTime":"0","summary":"Cabaletta Bio ( ($CABA) ) has provided an update. Cabaletta Bio, a biotechnology company developing engineered immune cell therapies for autoimmune...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","BK4139","IBB","DARP","FWD","SYNB","BBP","LNGR","IEIH","FHLC","JDOC","XT","BK4588","BK4585","RSPH","CABA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BMED","GNMX","LABU","TECB","MRNX","IYH","BK4139","PINK","IBRN","IBB","RSPH","TBXU","THNR","LFSC","BK4588","MEDI","SRRK","IDNA","PSCH","BBP","FRTY","BK4585","GDOC","IEIH","NVIB","MRNY","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667500316","title":"Bank of England predicted to raise interest rates this year","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500316","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667500316?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383602,"startTime":"0","endTime":"0","summary":"The Bank of England could raise interest rates this year.  The Bank of England will raise interest rates to four per cent by the end of the year, a top Wall Street bank has warned.Goldman Sachs has upgraded its interest rate expectations amid concerns that inflation could jump higher than previously expected.The bank said an interest rate hike this year was more likely as it revised up its inflation forecast for the beginning of 2027 to 3.9 per cent. A previous forecast suggested inflation would peak at 3.3 per cent later this year.However, the bank’s forecasters held that rates would be kept at 3.75 per cent when the MPC meets this Thursday. As many as four Bank officials out of the nine-strong MPC could demand higher borrowing rates due to concerns over rising energy prices.Goldman Sachs economists James Moberly and Sven Jari Stehn said there was “some risk” that the MPC signals an upcoming tightening in monetary policy later this week.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2024/05/Bank-of-England-2-1200x800-2.jpeg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2024/05/Bank-of-England-2-1200x800-2.jpeg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bank-of-england-predicted-to-raise-interest-rates-this-year/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bank-of-england-predicted-to-raise-interest-rates-this-year/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["07366","RJZ","TSLW","BK4582","CGDV","FXR","TACN","TSLO","CLIX","TSLQ","ISVL","BK4588","BBP","CRSH","BBEU","ELOL","TSLL","IJK","09366","IDEV","TESC","VAW","TSYY","TSLG","TSLS","UCC","TLA","TSLR","FLGB","TESL","TSLY","PEVC","TSLZ","LRCY","BK4585","TSDD","TSLT","ANEW","07766","TSLI","09766","KOMP","TSLP","AVSD","CAOS","FXL","TSL","TEST","DFUV","TSII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","RSPH","IBB","SYNB","NVIB","IYH","MRNX","LFSC","BK4139","IDNA","BK4179","TBXU","IEIH","PINK","FRTY","TECB","TLX","MRNY","PSCH","BMED","BK4585","GDOC","BBP","MEDI","FET","GNMX","XLVX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","TBXU","NVIB","RSPH","TECB","BK4588","SYNB","THNR","BK4139","IEIH","BMED","BK4585","IBB","SRRK","GNMX","MRNY","PINK","GDOC","LFSC","PSCH","IDNA","LABU","IYH","FRTY","BBP","IBRN","XLVX","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","GDOC","FRTY","NVIB","BK4588","LABU","IDNA","RSPH","BMED","BBP","MRNX","BK4585","GNMX","PINK","MEDI","IEIH","IBB","MRNY","TBXU","XLVX","SYNB","PSCH","TECB","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517941","title":"Nextbiomedical Targets Global Investors at 2026 KIS BioTech Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517941?lang=en_us&edition=fundamental","pubTime":"2026-09-11 09:44","pubTimestamp":1789091072,"startTime":"0","endTime":"0","summary":"The latest update is out from Nextbiomedical Co. Ltd. ( ($KR:389650) ). Nextbiomedical Co. Ltd., a biotechnology company, is strengthening its pres...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nextbiomedical-targets-global-investors-at-2026-kis-biotech-day?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nextbiomedical-targets-global-investors-at-2026-kis-biotech-day?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","BBP","ISBC","FHLC","XT","IBB","BK4585","IEIH","SYNB","BK4211","BK4588","LNGR","RSPH","DARP","JDOC","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666446516","title":"GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666446516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666446516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:02","pubTimestamp":1789074144,"startTime":"0","endTime":"0","summary":"The latest update is out from GeoVax Labs ( ($GOVX) ). GeoVax Labs, Inc., a clinical-stage biotechnology firm listed on Nasdaq as GOVX, develops va...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/geovax-updates-nasdaq-listing-amid-ongoing-clinical-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/geovax-updates-nasdaq-listing-amid-ongoing-clinical-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","BBC","FHLC","FWD","LCLG","RSPH","SYNB","AGNG","NQmain","JDOC","LU2065732104.USD","BK4588","XT","BK4585","IBB","BK4097","IEIH","BBP","DARP","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559053","title":"Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559053?lang=en_us&edition=fundamental","pubTime":"2026-09-11 01:51","pubTimestamp":1789062660,"startTime":"0","endTime":"0","summary":"Ninety percent of the expensive, widely used biologic drugs facing patent expiration by 2034 have no lower-cost alternatives in development, according to a new report by the Association for Accessible","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","IHE","BK4137","LU0128526141.USD","XLV","BK4585","LABU","HCSG","LU0029874061.USD","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530163","title":"Bank of America Reveals 5.22% Indirect Stake in Qiagen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530163","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530163?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:37","pubTimestamp":1788986261,"startTime":"0","endTime":"0","summary":"Qiagen ( ($QGEN) ) has issued an update. QIAGEN N.V., a Netherlands-based life sciences and biotechnology group focused on molecular diagnostics an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYG","LU2133065610.SGD","LU0648001328.SGD","LU2129689431.USD","BK4534","BBP","XT","RSPH","FNCL","BK4582","IYF","FWD","FHLC","LNGR","IEIH","HELX","XLF","IE00BKVL7J92.USD","JDOC","LU1496350502.SGD","HTEC","IE00B1BXHZ80.USD","FTXO","LU0256863811.USD","UYG","LU1280957306.USD","AGNG","DARP","BMED","LU0070302665.USD","LU0130517989.USD","IBB","KBWB","GNMX","SYNB","TFNS","LU1366192091.USD","LU0321505868.SGD","LU1718418525.SGD","LU0648000940.SGD","BAC","IE00B19Z3581.USD","LU0256863902.USD","LU1894683264.USD","PGF","VFH","BK4581","LU0314106906.USD","LU1804176565.USD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458412","title":"Revvity to acquire Human Cell Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458412","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458412?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:05","pubTimestamp":1788948328,"startTime":"0","endTime":"0","summary":"Revvity (RVTY) announced it has entered into a definitive agreement to acquire Human Cell Design, or HCD, a France-based biotechnology company spec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revvity-to-acquire-human-cell-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revvity-to-acquire-human-cell-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BN0W2T93.GBP","FHLC","SYNB","LNGR","BK4121","JDOC","BBP","IE00BLDYK493.USD","AGNG","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IEIH","IBB","DARP","RVTY","BK4588","BK4585","FWD","IE00B64QTZ34.USD","RSPH","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666301843","title":"Actinogen Medical Expands ASX-Quoted Share Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2666301843","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666301843?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:52","pubTimestamp":1788922334,"startTime":"0","endTime":"0","summary":"An announcement from Actinogen Medical ( ($AU:ACW) ) is now available. Actinogen Medical Limited, a biotechnology company listed on the ASX under t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-expands-asx-quoted-share-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-expands-asx-quoted-share-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","IEIH","SYNB","JDOC","DARP","FWD","IBB","FHLC","XT","BBP","AGNG","LNGR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTXH","FHLC","BBP","BME","MRNY","SBIO","CANC","XPH","IEIH","PBPH","IBBQ","AZNH","PSIL","MDTX","PTH","HYLG","FXH","MNTL","IBBJ","FBT","IDNA","IBRN","CNCR","PBE","PINK","GNOM","LFSC","HRTS","NVIB","SURI","MEDI","BBH","PSCH","GDOC","GPCR","JHMH","GNMX","LLYX","BIB","CURE","MEDX","APXH","IBB","JDOC","RSPH","TBXU","WDNA","GSKH","PJP","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APXH","GNMX","MDTX","MNTL","PINK","RSPH","MRNY","TBXU","BBH","GSKH","PSCH","SURI","MEDX","IBBQ","IDNA","BIB","PBE","HYLG","FHLC","GNOM","JHMH","LFSC","SBIO","SYNB","XPH","GPCR","CNCR","FBT","PTH","LENZ","WDNA","BBP","MEDI","IBRN","PJP","PSIL","BME","GDOC","IBBJ","JDOC","CURE","HRTS","FTXH","FXH","LLYX","NVIB","AZNH","CANC","PBPH","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340152","title":"CSL Seeks ASX Quotation for New Shares from Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340152","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340152?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:53","pubTimestamp":1788850386,"startTime":"0","endTime":"0","summary":"CSL ( ($AU:CSL) ) has provided an announcement. CSL Limited is a global biotechnology company that develops and supplies vaccines, plasma-derived t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/csl-seeks-asx-quotation-for-new-shares-from-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/csl-seeks-asx-quotation-for-new-shares-from-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FWD","XT","DARP","JDOC","BK4585","IEIH","FHLC","RSPH","SYNB","LNGR","IBB","AGNG","BBP","BK4588","PBPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342499","title":"Sandoz invests USD 300 million in new Slovenian biosimilar facility to boost capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342499","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342499?lang=en_us&edition=fundamental","pubTime":"2026-09-08 13:33","pubTimestamp":1788845596,"startTime":"0","endTime":"0","summary":"Sandoz Group Ltd ( ($CH:SDZ) ) has provided an announcement. Sandoz plans to invest around USD 300 million in a new biosimilar drug substance facil...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sandoz-invests-usd-300-million-in-new-slovenian-biosimilar-facility-to-boost-capacity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sandoz-invests-usd-300-million-in-new-slovenian-biosimilar-facility-to-boost-capacity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","CROC","USD","EUFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665344433","title":"Ceryvyn Therapeutics Plans Issue of 3 Million Long-Dated Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2665344433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665344433?lang=en_us&edition=fundamental","pubTime":"2026-09-08 12:37","pubTimestamp":1788842272,"startTime":"0","endTime":"0","summary":"Opthea ( ($AU:CYV) ) just unveiled an update. Ceryvyn Therapeutics Limited, an ASX-listed biotechnology company trading under the code CYV, develop...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ceryvyn-therapeutics-plans-issue-of-3-million-long-dated-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ceryvyn-therapeutics-plans-issue-of-3-million-long-dated-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","DARP","JDOC","IEIH","FHLC","SYNB","BK4007","BK4585","XT","BK4139","AGNG","RSPH","IBB","BK4588","BBP","FWD","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665396581","title":"Qurient Plans Investor Roadshow at 2026 KIS BioTech Day in Singapore and Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665396581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665396581?lang=en_us&edition=fundamental","pubTime":"2026-09-07 11:12","pubTimestamp":1788750740,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Qurient Co., Ltd. ( ($KR:115180) ). Qurient Co., Ltd., a Korea-based biotechnology company, is seeking to raise...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qurient-plans-investor-roadshow-at-2026-kis-biotech-day-in-singapore-and-hong-kong?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qurient-plans-investor-roadshow-at-2026-kis-biotech-day-in-singapore-and-hong-kong?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","IEIH","SYNB","STmain","JDOC","DARP","FWD","IBB","FHLC","XT","BBP","AGNG","LNGR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":2,"totalSize":178,"code":"91000000","status":"200"}]}}